Renalytix AI plc DSO Ratio 2011-2026 | RNLX

Annual DSO Ratio Renalytix AI plc

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
15.9	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
15.9	15.9	15.9

Quarterly DSO Ratio Renalytix AI plc

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
12.2	-	17.1	12.9	19.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
19.9	12.2	15.5

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Charles River Laboratories International CRL	65	$ 168.22	-3.26 %	$ 8.34 B	USA
Agilent Technologies A	63.8	$ 114.84	-0.55 %	$ 34.9 B	USA
Castle Biosciences CSTL	49.2	$ 24.73	-0.44 %	$ 687 M	USA
Danaher Corporation DHR	55.3	$ 192.12	0.53 %	$ 137 B	USA
DexCom DXCM	87	$ 63.21	1.59 %	$ 24.7 B	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Fulgent Genetics FLGT	77.4	$ 16.42	-2.38 %	$ 496 M	USA
Guardant Health GH	46.1	$ 89.66	-4.44 %	$ 11.2 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
ICON Public Limited Company ICLR	68.5	$ 109.62	-4.0 %	$ 9.04 B	Irlanda
CareDx, Inc CDNA	51.5	$ 17.82	-2.68 %	$ 950 M	USA
Illumina ILMN	61.3	$ 127.74	0.28 %	$ 20.3 B	USA
Burning Rock Biotech Limited BNR	31.7	$ 16.3	0.62 %	$ 175 M	China
IQVIA Holdings IQV	73.9	$ 170.72	-1.47 %	$ 29.3 B	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 274.46	0.27 %	$ 22.8 B	USA
Lantheus Holdings LNTH	80.5	$ 75.89	-0.28 %	$ 5.12 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Medpace Holdings MEDP	50.4	$ 496.0	-0.47 %	$ 14.3 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Mettler-Toledo International MTD	66.4	$ 1 266.63	0.53 %	$ 26.1 B	Schweiz
Myriad Genetics MYGN	52.3	$ 4.67	-1.68 %	$ 432 M	USA
ENDRA Life Sciences NDRA	7.11	$ 4.74	1.07 %	$ 3.73 M	USA
NeoGenomics NEO	77.7	$ 8.02	0.25 %	$ 1.03 B	USA
Neogen Corporation NEOG	66.6	$ 9.56	1.59 %	$ 2.07 B	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	29.4	$ 17.33	0.99 %	$ 388 M	USA
Natera NTRA	81.5	$ 204.87	-1.5 %	$ 20.2 B	USA
Biodesix BDSX	41.7	$ 15.36	1.92 %	$ 1.99 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Pacific Biosciences of California PACB	71.8	$ 1.42	5.97 %	$ 426 M	USA
Precipio PRPO	21.1	$ 25.98	1.64 %	$ 41.7 M	USA
Personalis PSNL	55.8	$ 6.58	-	$ 390 M	USA
RadNet RDNT	34.5	$ 55.06	0.49 %	$ 4.14 B	USA
Senseonics Holdings SENS	10.3	$ 6.69	-3.04 %	$ 279 M	USA
Sotera Health Company SHC	43.9	$ 14.87	-0.6 %	$ 4.22 B	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Soleno Therapeutics SLNO	27	$ 52.25	32.31 %	$ 2.66 B	USA
Neuronetics STIM	48.7	$ 1.76	15.79 %	$ 116 M	USA
Thermo Fisher Scientific TMO	70	$ 488.19	-0.67 %	$ 184 B	USA